Jakob Haldor Topsoe - 29 Jun 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
29 Jun 2023
Net transactions value
+$64,222
Form type
4
Filing time
03 Jul 2023, 18:46:15 UTC
Previous filing
28 Jun 2023
Next filing
03 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Purchase $31,846 +3,500 +4.7% $9.10 78,144 29 Jun 2023 Direct
transaction IGMS Common Stock Purchase $32,375 +3,500 +4.5% $9.25 81,644 30 Jun 2023 Direct
transaction IGMS Common Stock Award $0 +492 +0.6% $0.000000 82,136 30 Jun 2023 Direct F1
holding IGMS Common Stock 10,400,564 29 Jun 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 All shares are held directly by Topsoe Holding A/S. Jakob Haldor Topsoe, Christina Teng Topsoe, Anne Haugwitz-Hardenberg-Reventlow, Emil Oigaard, Thomas Schleicher and Birgitte Nielsen, members of the board of directors of Topsoe Holding A/S, may be deemed to share voting and investment power with respect to the shares reported herein and disclaim beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein, if any.